Advertisement Pfizer Forms Collaboration With Private Access - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pfizer Forms Collaboration With Private Access

The new online community aimed at increasing clinical trial awareness and participation

Pfizer has collaborated with Private Access to create a new online community aimed at increasing clinical trial awareness and participation. The site will focus on patient privacy rights to connect patients, physicians and researchers with tailored information, tools and technology that will lead to more informed decisions about patient care, including clinical trial participation industry-wide.

Pfizer’s collaboration with Private Access will help address patients’ and physicians’ top concerns, regarding research and clinical trials. The companies will work toward reducing the time needed to develop new and improved treatments by making it possible for researchers and investigators – based on express private access rights granted by the patient – to conduct more focused searches for clinical trial candidates.

Freda Lewis-Hall, chief medical officer of Pfizer, said: “With unprecedented collaboration among key groups, Pfizer and Private Access believe we can build the preeminent online clinical trial community to be used industry-wide to share knowledge while giving patients the confidence and control to share their health information.”